Hong Tian

2.2k total citations
110 papers, 1.5k citations indexed

About

Hong Tian is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Hong Tian has authored 110 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 24 papers in Immunology and 23 papers in Oncology. Recurrent topics in Hong Tian's work include Diabetes Treatment and Management (11 papers), Pancreatic function and diabetes (11 papers) and Immunotherapy and Immune Responses (10 papers). Hong Tian is often cited by papers focused on Diabetes Treatment and Management (11 papers), Pancreatic function and diabetes (11 papers) and Immunotherapy and Immune Responses (10 papers). Hong Tian collaborates with scholars based in China, United States and Belgium. Hong Tian's co-authors include Xiangdong Gao, Shu-Dong Qiu, Shantaram Bharadwaj, Anthony Atala, X. Peter, Yuanyuan Zhang, Wenbing Yao, Dang-xia Zhou, Wenbing Yao and Yan Liu and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and Blood.

In The Last Decade

Hong Tian

101 papers receiving 1.4k citations

Peers

Hong Tian
Qing Song China
Lian Ma China
Weijie Li China
Thanh Nguyen Singapore
Igor Bendik Switzerland
Qing Song China
Hong Tian
Citations per year, relative to Hong Tian Hong Tian (= 1×) peers Qing Song

Countries citing papers authored by Hong Tian

Since Specialization
Citations

This map shows the geographic impact of Hong Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Tian more than expected).

Fields of papers citing papers by Hong Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Tian. The network helps show where Hong Tian may publish in the future.

Co-authorship network of co-authors of Hong Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Tian. A scholar is included among the top collaborators of Hong Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Tian. Hong Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Lingxiao, et al.. (2025). Enhanced efficiency of MHC class II tumor neoantigen vaccines with a novel CD4+ T-cell helper epitope. Journal of Pharmacology and Experimental Therapeutics. 392(5). 103570–103570.
3.
Einsele, Hermann, Niels W.C.J. van de Donk, Bertrand Arnulf, et al.. (2021). CARTITUDE-2: Phase 2 Multicohort Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy, in Patients with Multiple Myeloma. Transplantation and Cellular Therapy. 27(3). S433–S434.
4.
Dai, Chang, Keith A. Webster, Amit Bhatt, et al.. (2021). Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies. International Journal of Molecular Sciences. 22(9). 4809–4809. 38 indexed citations
5.
Lu, Weisheng, Yongkang Wang, Peng Qian, et al.. (2021). An oral GLP-1 and GIP dual receptor agonist improves metabolic disorders in high fat-fed mice. European Journal of Pharmacology. 914. 174635–174635. 13 indexed citations
6.
Martin, Tom, Saad Z. Usmani, Jordan M. Schecter, et al.. (2021). Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma. Current Medical Research and Opinion. 37(10). 1779–1788. 34 indexed citations
7.
Tian, Hong, Tianhui Liu, Hong Liu, et al.. (2021). The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A‐PBX1: A 10‐year retrospective study. American Journal of Hematology. 96(11). 1461–1471. 15 indexed citations
8.
Xu, Mimi, Yujie Liu, Lijuan Qi, et al.. (2021). Clinical Outcomes of B Cell Acute Lymphoblastic Leukemia Patients Treated with Haploidentical Stem Cells Combined with Umbilical Cord Blood Transplantation. Transplantation and Cellular Therapy. 28(3). 173.e1–173.e6. 11 indexed citations
9.
Qian, Peng, Hong Tian, Yongkang Wang, et al.. (2020). A novel oral glucagon-like peptide 1 receptor agonist protects against diabetic cardiomyopathy via alleviating cardiac lipotoxicity induced mitochondria dysfunction. Biochemical Pharmacology. 182. 114209–114209. 30 indexed citations
10.
Jiang, Tao, Jianhua Luo, Yue Tong, et al.. (2019). Efficient Acquisition of Fully Human Antibody Genes against Self-Proteins by Sorting Single B Cells Stimulated with Vaccines Based on Nitrated T Helper Cell Epitopes. Journal of Immunology Research. 2019. 1–16. 6 indexed citations
11.
Li, Ran, Li Li, Ramraj Velmurugan, et al.. (2017). Targeting Phosphatidylserine with Calcium-Dependent Protein–Drug Conjugates for the Treatment of Cancer. Molecular Cancer Therapeutics. 17(1). 169–182. 17 indexed citations
12.
Tian, Hong, Yang Xu, Liming Liu, et al.. (2016). Comparison of outcomes in mixed phenotype acute leukemia patients treated with chemotherapy and stem cell transplantation versus chemotherapy alone. Leukemia Research. 45. 40–46. 26 indexed citations
13.
14.
Devineni, Damayanthi, David Polidori, Christopher R. Curtin, et al.. (2015). Single-dose Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Selective Inhibitor of Sodium Glucose Cotransporter 2, in Healthy Indian Participants. Clinical Therapeutics. 38(1). 89–98.e1. 12 indexed citations
15.
Yang, Zhen, Hong Tian, Yang Xu, et al.. (2014). [Clinical outcome of FLT3-ITD (+) acute myeloid leukemia patients treated with allogeneic hematopoietic stem cell transplantation].. PubMed. 53(2). 94–8. 2 indexed citations
16.
Wang, Haixu, Dang-xia Zhou, Jing Zhang, et al.. (2012). Effects of Paternal Occupation Exposure to Formaldehyde on Reproductive Outcomes. Journal of Occupational and Environmental Medicine. 54(5). 518–524. 19 indexed citations
17.
Gao, Mingming, et al.. (2012). A site-specific PEGylated analog of exendin-4 with improved pharmacokinetics and pharmacodynamics in vivo. Journal of Pharmacy and Pharmacology. 64(11). 1646–1653. 10 indexed citations
18.
Tian, Hong. (2010). Influences of Meteorological Conditions on Growing Period of Kentucky Bluegrass in Zoige Grassland. Zhongguo nongye qixiang. 1 indexed citations
19.
Chen, Mingjie, et al.. (2008). Site‐specific incorporation of unnatural amino acids into urate oxidase in Escherichia coli. Protein Science. 17(10). 1827–1833. 8 indexed citations
20.
Tian, Hong. (2001). The mass distribution of Chinese young males. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026